The Antibody Specificity Testing Market was valued at USD 928.06 million in 2024 and is anticipated to register a CAGR of 7.3% from 2025 to 2034, reaching USD 1,873.08 million by 2034. The market growth is driven by rising prevalence of infectious diseases, increasing adoption of immunotherapy and biologics, growing emphasis on accurate diagnostics, and demand for quality control in...

The Europe Antibody Specificity Testing Market was valued at USD 214.94 million in 2024 and is projected to register a CAGR of 7.3% from 2025 to 2034, reaching USD 433.81 million by 2034. The market growth is driven by rising demand for accurate diagnostic assays, increasing biopharmaceutical research, adoption of advanced antibody validation technologies, and strong regulatory...

The U.S. Antibody Specificity Testing Market was valued at USD 364.63 million in 2024 and is projected to reach USD 729.09 million by 2034, growing at a CAGR of 7.2% during the forecast period. The market growth is driven by increasing adoption of monoclonal antibodies, expanding biopharmaceutical research, growing need for accurate diagnostic assays, and regulatory compliance...